A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease
Clinical trial NCT05907668 · COMPLETED
Trial details
- NCT number
- NCT05907668
- Sponsor
- Immunovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2025-07-25
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.